RamasamyRVannucciSJYanSSHeroldKYanSFSchmidtAM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15:16R–28R.
2.
RojasAMercadalEFigueroaHMoralesMA. Advanced glycation and ROS: a link between diabetes and heart failure. Curr Vasc Pharmacol. 2008;6:44–51.
3.
Luevano-ContrerasCGomez-OjedaAMacias-CervantesMHGaray-SevillaME. Dietary advanced glycation end products and cardiometabolic risk. Curr Diab Rep. 2017;17:63.
4.
YamagishiSUedaSOkudaS. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. Curr Pharm Des. 2007;13:2832–6.
5.
O’BrienJMorrisseyPA. Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr. 1989;28:211–48.
6.
VistoliGDe MaddisDCipakAZarkovicNCariniMAldiniG. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res. 2013;47:3–27.
7.
OttCJacobsKHauckeENavarrete SantosAGruneTSimmA. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2:411–29.
8.
ArsovSGraaffRvan OeverenW, et al.Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin Chem Lab Med. 2014;52:11–20.
9.
ZhangWZhaoTZhaoYGuiDXuY. Advanced glycation end products in Chinese medicine mediated aging diseases: a review. Curr Vasc Pharmacol. 2019;18:322–33.
10.
MaessenDEStehouwerCDSchalkwijkCG. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci (Lond). 2015;128:839–61.
11.
VlassaraHCaiWGoodmanS, et al.Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the anti-inflammatory AGE receptor-1. J Clin Endocrinol Metab. 2009;94:4483–91.
12.
XanthisAHatzitoliosAFidaniSBefaniCGiannakoulasGKoliakosG. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes. Angiology. 2009;60:772–9.
13.
CaiWHeJCZhuLLuCVlassaraH. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A. 2006;103:13801–6.
14.
CoughlanMTThorburnDRPenfoldSA, et al.RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol. 2009;20:742–52.
15.
HegabZGibbonsSNeysesLMamasMA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4:90–102.
16.
StirbanAGawlowskiTRodenM. Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol Metab. 2014;3:94–108.
17.
Soro-PaavonenAZhangWZVenardosK, et al.Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens. 2010;28:780–8.
18.
UribarriJCaiWSanduOPeppaMGoldbergTVlassaraH. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461–6.
19.
Delgado-AndradeC. Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation. Food Funct. 2016;7:46–57.
20.
StirbanATschoepeD. Comment on “Advanced glycation endproducts in food and their effects on health” by Poulsen et al. (2013) Food and Chemical Toxicology 60, 10-37. Food Chem Toxicol. 2014;64:411.
21.
UribarriJWoodruffSGoodmanS, et al.Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110:911–16.
22.
CaiWRamdasMZhuLChenXStrikerGEVlassaraH. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A. 2012;109:15888–93.
23.
GrossinNAugerFNiquet-LeridonC, et al.Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol Nutr Food Res. 2015;59:927–38.
24.
Lopez-MorenoJQuintana-NavarroGMCamargoA, et al.Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome. Mol Nutr Food Res. 2017;61:1601029.
25.
Lopez-MorenoJQuintana-NavarroGMDelgado-ListaJ, et al.Mediterranean diet supplemented with coenzyme Q10 modulates the postprandial metabolism of advanced glycation end products in elderly men and women. J Gerontol A Biol Sci Med Sci. 2018;73:340–6.
26.
Lopez-MorenoJQuintana-NavarroGMDelgado-ListaJ, et al.Mediterranean diet reduces serum advanced glycation end products and increases antioxidant defenses in elderly adults: a randomized controlled trial. J Am Geriatr Soc. 2016;64:901–4.
27.
PoulsenMWAndersenJMHedegaardRV, et al.Short-term effects of dietary advanced glycation end products in rats. Br J Nutr. 2016;115:629–36.
28.
UribarriJStirbanASanderD, et al.Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care. 2007;30:2579–82.
29.
VlassaraHCaiWTrippE, et al.Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia. 2016;59:2181–92.
30.
MarkABPoulsenMWAndersenS, et al.Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care. 2014;37:88–95.
31.
HarcourtBESourrisKCCoughlanMT, et al.Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int. 2011;80:190–8.
32.
Di PinoACurrentiWUrbanoF, et al.Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects. J Clin Lipidol. 2016;10:1098–108.
